Acadian Asset Management LLC Brainstorm Cell Therapeutics Inc. Transaction History

Acadian Asset Management LLC

  • $32.5 Billion
  • Q2 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 10, 2022
SELL
$2.81 - $4.23 $100,859 - $151,827
-35,893 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$3.14 - $4.09 $324,801 - $423,069
-103,440 Reduced 74.24%
35,893 $118,000
Q2 2021

Aug 11, 2021
BUY
$3.01 - $4.01 $419,392 - $558,725
139,333 New
139,333 $529,000
Q4 2018

Feb 07, 2019
SELL
$2.98 - $3.9 $36,558 - $47,845
-12,268 Closed
0 $0
Q3 2018

Oct 30, 2018
BUY
$3.73 - $4.38 $45,759 - $53,733
12,268 New
12,268 $47,000

Others Institutions Holding BCLI

# of Institutions
54
Shares Held
12.3M
Call Options Held
169K
Put Options Held
30.6K
View Full List

About BRAINSTORM CELL THERAPEUTICS INC.

BCLI Quotes by TradingView
  • Ticker BCLI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 36,486,200
  • Market Cap $8.03M
  • Description
  • Brainstorm Cell Therapeutics Inc., a biotechnology company, engages in the development and commercialization of autologous cellular therapies for the treatment of neurodegenerative diseases. The company, through its NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem ...
More about BCLI
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email